The European Medicines Agency (EMA) is committed to supporting global efforts to respond to existing and emerging public health threats, such as antimicrobial resistance, biological and chemical threats and emergencies such as outbreaks or pandemics. The Agency has a number of mechanisms in place to contribute to global responses to such challenges...

The European Medicines Agency (EMA) responded to the 2022 outbreak of mpox disease by taking special measures to ensure the availability of critical treatments and vaccines, in close cooperation with its partners in the European medicines regulatory network. EMA's actions were in line with its newly formalised responsibilities for crisis...